Does Bluecross Blueshield Of Tennessee, INC. require prior authorization for Gardasil 9?
Bluecross Blueshield Of Tennessee, INC. does not require prior authorization for Gardasil 9 on the Medicare Part D plans that cover it.
No covering plan from this payer files a prior-authorization requirement for this drug.
By product strength
| RxNorm product | Plans covering | Require prior auth | Step therapy | Qty limit | Status |
|---|---|---|---|---|---|
| 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9]1597099 | 17 / 17 | 0 | 0 | 0 | No prior authorization |
| 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Prefilled Syringe [Gardasil 9]1597103 | 17 / 17 | 0 | 0 | 0 | No prior authorization |
Product names come from RxNorm (U.S. National Library of Medicine).
Plan-by-plan detail — 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9]
Gardasil 9 has 2 products in the corpus; this table is for 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9], the one carried on the most plans. The product table above covers every strength.
| Plan | Contract | Tier | Prior auth | Step therapy | Qty limit |
|---|---|---|---|---|---|
| BlueAdvantage Diamond (PPO) | H7917-009 | 3 | No | No | No |
| BlueAdvantage Diamond (PPO) | H7917-010 | 3 | No | No | No |
| BlueAdvantage Diamond (PPO) | H7917-011 | 3 | No | No | No |
| BlueAdvantage Extra (PPO) | H7917-041 | 3 | No | No | No |
| BlueAdvantage Garnet (PPO) | H7917-032 | 3 | No | No | No |
| BlueAdvantage Garnet (PPO) | H7917-033 | 3 | No | No | No |
| BlueAdvantage Ruby (PPO) | H7917-012 | 3 | No | No | No |
| BlueAdvantage Ruby (PPO) | H7917-013 | 3 | No | No | No |
| BlueAdvantage Ruby (PPO) | H7917-014 | 3 | No | No | No |
| BlueAdvantage Ruby (PPO) | H7917-015 | 3 | No | No | No |
| BlueAdvantage Sapphire (PPO) | H7917-030 | 3 | No | No | No |
| BlueAdvantage Sapphire (PPO) | H7917-031 | 3 | No | No | No |
| BlueAdvantage Sapphire (PPO) | H7917-038 | 3 | No | No | No |
| BlueAdvantage Sapphire (PPO) | H7917-040 | 3 | No | No | No |
| BlueAdvantage Total Heart and Diabetes (PPO C-SNP) | H7917-044 | 3 | No | No | No |
| BlueAdvantage Total Heart and Diabetes (PPO C-SNP) | H7917-045 | 3 | No | No | No |
| BlueAdvantage Total Heart and Diabetes Plus (PPO C-SNP) | H7917-046 | 3 | No | No | No |
- Effective
- 2026-06-30
- Retrieved
- 2026-07-19
- SHA-256
- e626e6bcda1aa6a0071e6f0df6bafe686ae41842cdf0a9feffdc649b6d3ff3ae
We publish the hash of the exact file we ingested so any answer can be audited against the bytes CMS served that day.
Gardasil 9 at other payers
Administrative information only. Benefily reports what a payer has published in its own prior-authorization policy as of the effective date shown. It is not medical advice, not a coverage or payment guarantee, and not an authorization. Requirements vary by plan, place of service and member benefits — always verify with the payer before rendering service.